- RetroSense Using Optogenetics to Treat Retinitis Pigmentosa and Dry AMD
- Hemera Biosciences Obtains Initial Funding for Gene-based Treatment for AMD
- Probing to Treat Meibomian Gland Dysfunction
- Discovery About Shape of the Eye Could Boost Effectiveness of Artificial Lenses Used in Cataract Surgery
- DARPins, The Next “Game Changer” for Wet AMD?
Contact This Office
Establishing good communications between our current patients and potential patients is important to TSO. If you have a question, concern, or comment to make, please call or email us and we will respond back to you within a maximum of 24 hours.